New Delhi [India], January 5 (ANI): The Indian Council of Medical Research (ICMR) director Dr Balram Bhargava on Tuesday said that in a pandemic situation, restricted emergency use of the vaccine is considered based on phase 2 safety and immunogenicity clinical trial data while phase thre
New Delhi [India], January 5 (ANI): The Prime Minister's Citizen Assistance and Relief in Emergency Situations (PM CARES) Fund Trust is allocating Rs 201.58 crores for installation of additional 162 dedicated Pressure Swing Adsorption (PSA) Medical Oxygen Generation Plants inside public heal
New Delhi [India], January 5 (ANI): Days after Drugs Controller General of India (DCGI) gave approval to two COVID-19 vaccines, Union Health Secretary Rajesh Bhushan on Tuesday said that India is prepared to roll out vaccine within 10 days of emergency use authorisation (EUA), subject to
Hyderabad (Telangana) [India], January 4 (ANI): The emergency use approval for Covaxin is "a giant leap for innovation and novel product development" in India and the "goal is to provide global access to populations that need it the most", Bharat Biotech chairman and managing director Dr
New Delhi [India], January 4 (ANI): A day after Union Civil Aviation Minister Hardeep Singh Puri called Shashi Tharoor a cynic for criticising the Drugs Controller General of India's (DCGI) approval of COVAXIN for "restricted use in an emergency situation" without this COVID-19 vaccine havin
New Delhi [India], January 4 (ANI): After the drug regulator of the country gave in principle approval for restricted emergency use to two indigenously made vaccines, Bharatiya Janata Party (BJP) spokesperson Sambit Patra on Monday said that when India's scientists develop things for public
New Delhi [India], January 4 (ANI): A day after the Drugs Controller General of India (DCGI) gave its nod for the emergency use approval for two indigenous vaccines against COVID-19 on Sunday, Vice President M Venkaiah Naidu on Monday termed it as India's leap of science and manifestation
Mumbai (Maharashtra) [India], January 4 (ANI): Equity benchmark indices continued their upward march during early hours on Monday after the Drug Controller General of India approved Covid vaccines produced by AstraZeneca and Bharat Biotech for emergency use in the country.
Tokyo [Japan], January 4 (ANI): Japanese government is preparing to declare another state of emergency in Tokyo and three neighbouring prefectures, due to the spike in coronavirus infections in the country, Kyodo News reported citing a source on Monday.
New Delhi [India], January 3 (ANI): All India Institute of Medical Sciences (AIIMS) director Dr Randeep Guleria on Sunday clarified that approval of COVAXIN, Bharat Biotech's COVID-19 vaccine is for an emergency situation and not emergency use authorisation which is given to Serum Institute
New Delhi [India], January 3 (ANI): Drugs Controller General of India (DCGI) on Sunday said the permission given to Bharat Biotech's COVAXIN is "for restricted use in an emergency situation" and it is given in "public interest as an abundant precaution" as the vaccine is still in clinical tr
Noida (Uttar Pradesh) [India], January 3 (ANI): Kumar Kundan, a journalist who volunteered for human trials of Bharat Biotech's Covid vaccine, refuted rumours about the side effects of "Covaxin" as the Drugs Controller General of India (DCGI) has finally given approval for the vaccine agains